These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


412 related items for PubMed ID: 35175342

  • 1. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC, Shlipak MG, Scherzer R, Bauer SR, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2148940. PubMed ID: 35175342
    [Abstract] [Full Text] [Related]

  • 2. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC, Shlipak MG, Scherzer R, Bansal N, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM.
    Am J Kidney Dis; 2022 Dec 01; 80(6):762-772.e1. PubMed ID: 35817274
    [Abstract] [Full Text] [Related]

  • 3. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM, Sang Y, Grams ME, Ballew SH, Surapaneni A, Matsushita K, Go AS, Shlipak MG, Inker LA, Eneanya ND, Crews DC, Powe NR, Levey AS, Coresh J, Chronic Kidney Disease Prognosis Consortium.
    JAMA; 2022 Jun 21; 327(23):2306-2316. PubMed ID: 35667006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA, Ix JH, Shlipak MG, Katz R, Hawfield AT, Rocco MV, Ambrosius WT, Cho ME, Pajewski NM, Rastogi A, Rifkin DE.
    Am J Kidney Dis; 2020 Dec 21; 76(6):765-774. PubMed ID: 32682697
    [Abstract] [Full Text] [Related]

  • 7. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J, Liu Y, Jin R, Zhao X, Wu Z, Han Z, Xu Z, Guo X, Tao L.
    Nephrol Dial Transplant; 2024 Apr 26; 39(5):860-872. PubMed ID: 37930847
    [Abstract] [Full Text] [Related]

  • 8. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW, Grams ME, Inker LA, Coresh J, Selvin E.
    Diabetes Care; 2014 Apr 26; 37(4):1002-8. PubMed ID: 24271191
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Ide H, Iwase M, Fujii H, Ohkuma T, Kaizu S, Jodai T, Kikuchi Y, Idewaki Y, Sumi A, Nakamura U, Kitazono T.
    Clin Exp Nephrol; 2017 Jun 26; 21(3):383-390. PubMed ID: 27339449
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW, Rule AD, Voskoboev N, Baumann NA, Lieske JC.
    Clin Chem; 2015 Oct 26; 61(10):1265-72. PubMed ID: 26240296
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
    Fan L, Inker LA, Rossert J, Froissart M, Rossing P, Mauer M, Levey AS.
    Nephrol Dial Transplant; 2014 Jun 26; 29(6):1195-203. PubMed ID: 24449101
    [Abstract] [Full Text] [Related]

  • 15. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC, Scherzer R, Ix JH, Kramer HJ, Crews DC, Nadkarni G, Gutierrez O, Bullen AL, Ilori T, Garimella PS, Shlipak MG, Estrella MM.
    Am J Kidney Dis; 2024 Apr 26; 83(4):489-496.e1. PubMed ID: 37866793
    [Abstract] [Full Text] [Related]

  • 16. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL, White CA, Norman PA, Knoll GA, Tangri N, Sood MM, Hiremath S, Burns KD, McCudden C, Akbari A.
    Am J Kidney Dis; 2022 Oct 26; 80(4):462-472.e1. PubMed ID: 35588905
    [Abstract] [Full Text] [Related]

  • 17. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
    Chen DC, Lu K, Scherzer R, Lees JS, Rutherford E, Mark PB, Potok OA, Rifkin DE, Ix JH, Shlipak MG, Estrella MM.
    Kidney Med; 2024 Apr 26; 6(4):100796. PubMed ID: 38567244
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.
    Khalid UB, Haroon ZH, Aamir M, Ain QU, Mansoor K, Jaffar SR.
    J Coll Physicians Surg Pak; 2020 Jul 26; 30(7):701-706. PubMed ID: 32811598
    [Abstract] [Full Text] [Related]

  • 19. Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings.
    Liu L, Chang DY, Lewandrowski KB, Dighe AS.
    Clin Biochem; 2024 Oct 26; 131-132():110801. PubMed ID: 39029611
    [Abstract] [Full Text] [Related]

  • 20. CKD Prevalence and Incidence in Older Adults Using Estimated GFR With Different Filtration Markers: The Atherosclerosis Risk in Communities Study.
    Flaherty CM, Surapaneni A, Seegmiller JC, Coresh J, Grams ME, Ballew SH.
    Kidney Med; 2024 Oct 26; 6(10):100893. PubMed ID: 39319210
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.